Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Smarter screening: could a simple score reduce unnecessary biopsies?

NCT ID NCT05870787

Diagnosis Sponsor: University of Aarhus Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new colposcopy method that uses a scoring system (Swede score) to better diagnose cervical precancer in women with abnormal screening results. Researchers enrolled 929 women referred for colposcopy to see if the scoring system could accurately identify precancer and safely reduce the number of biopsies needed. The goal is to improve diagnosis while avoiding unnecessary procedures.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Swede score colposcopy (diagnostic test)
What this could lead to
If successful, this scoring system could make cervical precancer diagnosis more accurate and reduce the need for multiple biopsies.
What could go wrong
This is a completed diagnostic study, not a treatment trial. The scoring system may not be adopted widely or may not perform as well in other populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

929 people

The number who actually took part.

Started

Mar 2023

Finished

Dec 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Women with abnormal smear (HPV-genotype and cytology) referred to colposcopy, visibel transformation zone (type 1 or 2) and where cervical biopsies has been sent to pathology examination.

Ages

23 to 99 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Women referred to colposcopy due to abnormal smear (HPV-genotype and cytology) in Central Denmark Region or Southern Denmark Region. Exclusion Criteria: * Allergic to iodine. * Tranformationzone not visible (type 3). * Atrophy of cervical epithelium. * Women referred to colposcopy with no cervical biopsies taken or invalid cervical biopsies. * Women with previous hysterectomy or without a cervix due to cervical cancer will be excluded. * Pregnant women.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cervical cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cervical cancer cervical intraepithelial neoplasia cervical intraepithelial neoplasia grade 2/3 cervix disorder dysplasia of cervix Uterine Cervical Neoplasms uterine cervix neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cervical cancer Cervical disease Cervical dysplasia Cervical lesion Cervical neoplasm

Contacts and locations

Locations

  • Guldberg Kvindeklinik

    Fredericia, Fredericia, 7000, Denmark

  • Gødstrup Regional Hospital

    Herning, Herning, 7400, Denmark

  • Horsens Gynækologisk Klinik

    Horsens, Horsens, 8700, Denmark

  • Horsens Regional Hospital

    Horsens, Horsens, 8700, Denmark

  • Odense Univeristy Hospital

    Odense, Odense, 5000, Denmark

  • Randers Regional Hospital

    Randers, Randers, 8900, Denmark

  • Viborg Regional Hospital

    Viborg, Viborg, 8800, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.